These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36854016)

  • 1. Polydopamine-Coated Radiolabeled Microspheres for Combinatorial Radioembolization and Photothermal Cancer Therapy.
    Wu M; Zhang L; Shi K; Zhao D; Yong W; Yin L; Huang R; Wang G; Huang G; Gao M
    ACS Appl Mater Interfaces; 2023 Mar; 15(10):12669-12677. PubMed ID: 36854016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastable PLGA-Coated
    Jin S; Huang J; Dong Y; Hu D; Sun J; Li Z; Zhong BY; Liu Z; Zhu R; Wang G
    Mol Pharm; 2024 Jul; 21(7):3407-3415. PubMed ID: 38822792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer composite microspheres loading
    Xiao L; Li Y; Geng R; Chen L; Yang P; Li M; Luo X; Yang Y; Li L; Cai H
    Biomater Res; 2023 Nov; 27(1):110. PubMed ID: 37925456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
    Fidelman N; Kerlan RK
    AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radionuclide-Labeled Microspheres for Radio-Immunotherapy of Hepatocellular Carcinoma.
    Yang S; Mu C; Liu T; Pei P; Shen W; Zhang Y; Wang G; Chen L; Yang K
    Adv Healthc Mater; 2023 Oct; 12(26):e2300944. PubMed ID: 37235739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine-131-Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor.
    Jia G; Wang T; Li R; Li X; Sun G; Chen W; Peng Y; Cheng C; Yang J; Zuo C
    Adv Healthc Mater; 2023 Dec; 12(32):e2301559. PubMed ID: 37807421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life.
    Agirrezabal I; Brennan VK; Colaone F; Shergill S; Pereira H; Chatellier G; Vilgrain V
    Adv Ther; 2022 May; 39(5):2035-2051. PubMed ID: 35279814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.
    Moreno-Luna LE; Yang JD; Sanchez W; Paz-Fumagalli R; Harnois DM; Mettler TA; Gansen DN; de Groen PC; Lazaridis KN; Narayanan Menon KV; Larusso NF; Alberts SR; Gores GJ; Fleming CJ; Slettedahl SW; Harmsen WS; Therneau TM; Wiseman GA; Andrews JC; Roberts LR
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):714-23. PubMed ID: 23093355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Salem R; Lewandowski RJ
    Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Wu X; Ge L; Shen G; He Y; Xu Z; Li D; Mu C; Zhao L; Zhang W
    ACS Appl Mater Interfaces; 2022 May; 14(19):21848-21859. PubMed ID: 35507826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First
    De La Vega JC; Esquinas PL; Rodríguez-Rodríguez C; Bokharaei M; Moskalev I; Liu D; Saatchi K; Häfeli UO
    Theranostics; 2019; 9(3):868-883. PubMed ID: 30809314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization for the treatment of hepatocellular carcinoma.
    Kim HC
    Clin Mol Hepatol; 2017 Jun; 23(2):109-114. PubMed ID: 28494530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin α
    Li Y; Hu P; Wang X; Hou X; Liu F; Jiang X
    Regen Biomater; 2021 Oct; 8(5):rbab046. PubMed ID: 34457350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A versatile UCST-type composite microsphere for image-guided chemoembolization and photothermal therapy against liver cancer.
    Huang D; Dai H; Tang K; Chen B; Zhu H; Chen D; Li N; Wang Y; Liu C; Huang Y; Yang J; Zhang C; Lin R; He W
    Nanoscale; 2020 Oct; 12(38):20002-20015. PubMed ID: 32996987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series.
    Rose SC; Narsinh KH; Newton IG
    J Vasc Interv Radiol; 2017 Jan; 28(1):103-110. PubMed ID: 27840042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
    Kim DY; Han KH
    Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
    Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
    J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.
    Lewandowski RJ; Kulik LM; Riaz A; Senthilnathan S; Mulcahy MF; Ryu RK; Ibrahim SM; Sato KT; Baker T; Miller FH; Omary R; Abecassis M; Salem R
    Am J Transplant; 2009 Aug; 9(8):1920-8. PubMed ID: 19552767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.